Skip to main content
CSPC Pharmaceutical Group Limited logo

CSPC Pharmaceutical Group Limited — Investor Relations & Filings

Ticker · 1093 ISIN · US12591J1088 LEI · 529900M3XQCW234H8O91 HKEX Manufacturing
Open in API
Filings indexed 1,521 across all filing types
Latest filing 2022-01-10 Regulatory Filings
Country HK Hong Kong
Listing HKEX 1093

About CSPC Pharmaceutical Group Limited

https://www.cspc.com.hk/en/global/home.…

CSPC Pharmaceutical Group Limited is a comprehensive enterprise specializing in the research, development, manufacturing, and sale of pharmaceutical products. The company operates across two main segments: finished drugs and bulk drugs. It emphasizes innovation and new drug development, evidenced by substantial R&D investment, to produce high-quality, effective, and reliable medicines. Its portfolio includes key innovative products such as NBP (soft capsules and injections), Oulaining, and Enxi, which are among its top-selling drugs.

Recent filings

Filing Released Lang Actions
VOLUNTARY ANNOUNCEMENT - "ZOLEDRONIC ACID INJECTION" OBTAINS DRUG REGISTRATION APPROVAL
Regulatory Filings Classification · 95% confidence The document is a voluntary announcement by the board of directors of CSPC Pharmaceutical Group Limited regarding the drug registration approval of a product called Zoledronic Acid Injection. It is a short announcement (2429 characters) that informs about a regulatory approval event and does not contain financial data, financial statements, or detailed report content. It is not an annual report, earnings release, or any detailed financial or management report. It is also not a voting result, capital change, or legal proceeding. The document is an announcement of a regulatory milestone related to the company's product portfolio. Given the short length and nature of the content, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2022-01-10 English
NEXT DAY DISCLOSURE RETURN
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks by CSPC Pharmaceutical Group Limited. It includes detailed data on repurchases of shares, dates, quantities, prices, and confirmations of compliance with listing rules on the Stock Exchange of Hong Kong. The content focuses on share repurchase activities and capital changes rather than financial results, management commentary, or regulatory certifications. The document length is 9038 characters, which is substantive and contains detailed transactional data. This matches the description of a 'Transaction in Own Shares' filing, which reports company buybacks or sales of its own shares. Therefore, the appropriate classification is POS (Transaction in Own Shares).
2022-01-03 English
(REVISED) NEXT DAY DISCLOSURE RETURN
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks by CSPC Pharmaceutical Group Limited. It details repurchases of shares on specific dates, quantities, and prices, referencing compliance with the Main Board Listing Rules and GEM Listing Rules of the Stock Exchange of Hong Kong. The content focuses on share repurchase activities and capital changes rather than financial results, management commentary, or regulatory certifications. This matches the definition of a 'Transaction in Own Shares' filing, which reports company buybacks or sales of its own shares. The document length is sufficient and contains detailed transactional data, not just an announcement or certification, so it is not an RPA or RNS. Therefore, the appropriate classification is POS (Transaction in Own Shares).
2022-01-03 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 DECEMBER 2021
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return for Equity Issuer and Hong Kong Depositary Receipts listed under Chapter 19B of the Exchange Listing Rules on Movements in Securities' for the month ended 31 December 2021. It details movements in issued shares, share options, repurchases, and other share capital changes for CSPC Pharmaceutical Group Limited. The document is a regulatory submission to the Hong Kong Exchanges and Clearing Limited, reporting share capital movements and share repurchases. It does not contain financial statements, earnings data, or management discussion. It is a regulatory filing related to share capital movements and not a full financial report or announcement of a report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2022-01-03 English
NEXT DAY DISCLOSURE RETURN
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks by CSPC Pharmaceutical Group Limited. It includes detailed data on repurchases of shares, dates, quantities, prices, and confirmations of compliance with listing rules. The document references specific listing rules from the Stock Exchange of Hong Kong and provides a purchase report for shares repurchased on the exchange. This type of document is a formal announcement of share repurchase activity and changes in capital structure, not a full financial report or earnings release. It fits the category of 'Transaction in Own Shares' (POS), which covers company buybacks or sales of its own shares.
2021-12-31 English
NEXT DAY DISCLOSURE RETURN
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks by CSPC Pharmaceutical Group Limited. It includes detailed data on repurchases of shares, dates, quantities, prices, and confirmations of compliance with listing rules. The document references specific listing rules from the Stock Exchange of Hong Kong and provides transactional details of share repurchases. This matches the description of a 'Transaction in Own Shares' filing, which reports company buybacks or sales of its own shares. The document length is 8737 characters, containing substantive data, not merely an announcement or certification. Therefore, the appropriate classification is POS (Transaction in Own Shares).
2021-12-30 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.